OrthoTrophix Announces Early Completion of Enrollment in Phase 2b Trial of TPX-100 in Knee Osteoarthritis
FOSTER CITY, Calif., Feb. 24, 2026 /PRNewswire/ — OrthoTrophix, Inc., a privately held biopharmaceutical company developing novel investigational therapies for…
